Starboard Value Is to Take Stake in Bristol-Myers Squibb
Bristol-Myers Squibb Co. brand medication sits on a pharmacy shelf. (Photographer: George Frey/Bloomberg)

Starboard Value Is to Take Stake in Bristol-Myers Squibb

(Bloomberg) -- Starboard Value has taken a stake in Bristol-Myers Squibb, the pharmaceutical giant that agreed to acquire Celgene Corp. in a record $74 billion deal last month, according to people ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.